329 related articles for article (PubMed ID: 30606195)
1. Pathological evaluation of neoadjuvant chemotherapy in advanced gastric cancer.
Hu SB; Liu CH; Wang X; Dong YW; Zhao L; Liu HF; Cao Y; Zhong DR; Liu W; Li YL; Gao WS; Bai CM; Shang ZH; Li XY
World J Surg Oncol; 2019 Jan; 17(1):3. PubMed ID: 30606195
[TBL] [Abstract][Full Text] [Related]
2. A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer.
Wang X; Zhao L; Liu H; Zhong D; Liu W; Shan G; Dong F; Gao W; Bai C; Li X
Br J Cancer; 2016 Jun; 114(12):1326-33. PubMed ID: 27172250
[TBL] [Abstract][Full Text] [Related]
3. [Postoperative complications and their influence on the prognosis factors in gastric cancer patients receiving neoadjuvant treatment].
Wang TB; Mao QK; Zhang XJ; Zhou H; Guo CG; Chen YT; Zhao DB
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):160-166. PubMed ID: 33508922
[No Abstract] [Full Text] [Related]
4. Different prognostic implication of ypTNM stage and pTNM stage for gastric cancer: a propensity score-matched analysis.
Li Z; Wang Y; Ying X; Shan F; Wu Z; Zhang L; Li S; Jia Y; Ren H; Ji J
BMC Cancer; 2019 Jan; 19(1):80. PubMed ID: 30651085
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
[TBL] [Abstract][Full Text] [Related]
6. Postoperative nodal status and diffuse-type histology are independent prognostic factors in resectable advanced gastric carcinomas after preoperative chemotherapy.
Koh YW; Park YS; Ryu MH; Ryoo BY; Park HJ; Yook JH; Kim BS; Kang YK
Am J Surg Pathol; 2013 Jul; 37(7):1022-9. PubMed ID: 23715160
[TBL] [Abstract][Full Text] [Related]
7. [Clinical features and prognosis analysis of 21 gastric cancer patients with pathological complete response after neoadjuvant chemotherapy].
Peng L; Yang W; Zhang Z; Liu H; Hua Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1168-1173. PubMed ID: 29130233
[TBL] [Abstract][Full Text] [Related]
8. Pathological response measured using virtual microscopic slides for gastric cancer patients who underwent neoadjuvant chemotherapy.
Kawai S; Shimoda T; Nakajima T; Terashima M; Omae K; Machida N; Yasui H
World J Gastroenterol; 2019 Sep; 25(35):5334-5343. PubMed ID: 31558877
[TBL] [Abstract][Full Text] [Related]
9. Is pathologic tumor regression grade after neo-adjuvant chemotherapy a promising prognostic indicator for patients with locally advanced gastric cancer? A cohort study evaluating tumor regression response.
Xu X; Zheng G; Zhang T; Zhao Y; Zheng Z
Cancer Chemother Pharmacol; 2019 Sep; 84(3):635-646. PubMed ID: 31230156
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy in controlling lymph node metastasis for locally advanced gastric cancer in a Chinese population.
Dong S; Yu JR; Zhang Q; Liu XS
J Chemother; 2016; 28(1):59-64. PubMed ID: 25977986
[TBL] [Abstract][Full Text] [Related]
11. [Predictive and Prognostic significance of high-sensitivity modified Glasgow Prognostic Score (HS-mGPS) in advanced gastric cancer patients treated with neoadjuvant chemotherapy].
Cui Y; Li J; Cao YH; Liu MY; Shi ZX; Gao TH
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):195-200. PubMed ID: 28316218
[No Abstract] [Full Text] [Related]
12. Prognostic analysis of stage III gastric cancer after curative surgery according to the newest TNM classification.
Wei J; Yao T; Wang Y; Li L; Pan C; Zhang N
Clin Transl Oncol; 2019 Feb; 21(2):232-238. PubMed ID: 29968135
[TBL] [Abstract][Full Text] [Related]
13. Prediction of response and prognosis by a score including only pretherapeutic parameters in 410 neoadjuvant treated gastric cancer patients.
Lorenzen S; Blank S; Lordick F; Siewert JR; Ott K
Ann Surg Oncol; 2012 Jul; 19(7):2119-27. PubMed ID: 22395980
[TBL] [Abstract][Full Text] [Related]
14. Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.
Zhu Y; Sun Y; Hu S; Jiang Y; Yue J; Xue X; Yang L; Xue L
BMC Gastroenterol; 2017 Mar; 17(1):41. PubMed ID: 28292272
[TBL] [Abstract][Full Text] [Related]
15. The Role of Surgical Resection for Stage IV Gastric Cancer With Synchronous Hepatic Metastasis.
Picado O; Dygert L; Macedo FI; Franceschi D; Sleeman D; Livingstone AS; Merchant N; Yakoub D
J Surg Res; 2018 Dec; 232():422-429. PubMed ID: 30463751
[TBL] [Abstract][Full Text] [Related]
16. Treatment of locally advanced gastric cancer with the XELOX program of neoadjuvantchemotherapy combined with laparoscopic surgery: the experience in China.
Zheng CH; Lu J; Huang CM; Li P; Xie JW; Wang JB; Lin JX
Hepatogastroenterology; 2014 Oct; 61(135):1876-82. PubMed ID: 25713882
[TBL] [Abstract][Full Text] [Related]
17. [Effects of XELOX regimen as neoadjuvant chemotherapy on radical resection rate and prognosis in patients with advanced gastric cancer].
Zhao Q; Li Y; Tan BB; Tian Y; Jiao ZK; Zhao XF; Zhang ZD; Wang D; Yang PG
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):773-7. PubMed ID: 24378101
[TBL] [Abstract][Full Text] [Related]
18. ypTNM staging after neoadjuvant chemotherapy in the Chinese gastric cancer population: an evaluation on the prognostic value of the AJCC eighth edition cancer staging system.
Li Z; Wang Y; Shan F; Ying X; Wu Z; Xue K; Miao R; Zhang Y; Ji J
Gastric Cancer; 2018 Nov; 21(6):977-987. PubMed ID: 29748876
[TBL] [Abstract][Full Text] [Related]
19. Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases.
Becker K; Langer R; Reim D; Novotny A; Meyer zum Buschenfelde C; Engel J; Friess H; Hofler H
Ann Surg; 2011 May; 253(5):934-9. PubMed ID: 21490451
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of neoadjuvant chemotherapy with docetaxel, cisplatin and S-1 for resectable locally advanced gastric cancer.
Migita K; Nashimoto A; Yabusaki H; Matsuki A; Aizawa M
Int J Clin Oncol; 2016 Feb; 21(1):102-9. PubMed ID: 26017926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
